Physician profile
Charles Y Liu
NPI 1568406080
$8,810.88
in general payments reported to CMS, 2019-2025
12 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2021: $596 · 2022: $3,141 · 2023: $1,196 · 2024: $3,335 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $934 · Travel and Lodging: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $934.48 |
| Travel and Lodging | $784.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,099.69 | 2022-2024 | Pipeline, Activa Pc |
| Neuropace, INC. | $1,265.55 | 2019-2024 | |
| Microtransponder, INC. | $806.09 | 2022-2025 | |
| Longeviti Neuro Solutions INC | $596.95 | 2021-2025 | Clearfit |
| Livanova USA, INC. | $397.85 | 2019-2022 | |
| Mml US, INC. | $209.54 | 2021 | |
| Applied Medical Resources Corporation | $175.00 | 2022 | |
| Boston Scientific Corporation | $169.37 | 2024 | Watchman Flx |
| Medtronic USA, INC. | $32.87 | 2019 | |
| Digital Surgery Systems, INC. | $26.26 | 2025 | Aesculap |
| Globus Medical, INC. | $16.44 | 2025 | |
| Urogen Pharma, INC. | $15.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.